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Osteoarthritis (OA), primarily characterized by carti-
lage degeneration, is caused by an imbalance
between anabolic and catabolic factors. Here, we
investigated the role of zinc (Zn2+) homeostasis,
Zn2+ transporters, and Zn2+-dependent transcription
factors in OA pathogenesis. Among Zn2+ trans-
porters, the Zn2+ importer ZIP8was specifically upre-
gulated in OA cartilage of humans andmice, resulting
in increased levels of intracellular Zn2+ in chondro-
cytes. ZIP8-mediated Zn2+ influx upregulated the
expression of matrix-degrading enzymes (MMP3,
MMP9, MMP12, MMP13, and ADAMTS5) in chondro-
cytes. Ectopic expression of ZIP8 in mouse cartilage
tissue caused OA cartilage destruction, whereas
Zip8 knockout suppressed surgically induced OA
pathogenesis, with concomitant modulation of Zn2+
influx and matrix-degrading enzymes. Furthermore,
MTF1 was identified as an essential transcription
factor in mediating Zn2+/ZIP8-induced catabolic fac-
tor expression, and genetic modulation of Mtf1 in
mice altered OA pathogenesis. We propose that the
zinc-ZIP8-MTF1 axis is an essential catabolic regu-
lator of OA pathogenesis.INTRODUCTION
Osteoarthritis (OA) is themost common of all arthropathies and is
a leading cause of disability with a large socioeconomic cost. To
date, however, no effective disease-modifying therapies for OA
have been developed. OA is primarily characterized by cartilage
destruction but also involves other pathological changes,
including synovial inflammation, osteophyte formation, and sub-
chondral bone sclerosis, in all tissues of joints (Bian et al., 2012;
Loeser et al., 2012; Little and Hunter, 2013). OA pathogenesis is
caused by an imbalance between anabolic and catabolic fac-730 Cell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc.tors. A variety of etiologic risk factors and pathophysiological
processes contribute to the progressive nature of the disease.
Important among potential OA-causing mechanisms are me-
chanical stresses, including joint instability and injury, and fac-
tors that predispose toward OA, such as aging. These factors
lead to the activation of biochemical pathways in chondrocytes
that result in degradation of the extracellular matrix by matrix
metalloproteinases (MMPs) and aggrecanases (ADAMTSs).
Among matrix-degrading enzymes, MMP3, MMP13, and
ADAMTS5 are known to play crucial roles in OA cartilage
destruction (Blom et al., 2007; Glasson et al., 2005; Little et al.,
2009).
Matrix-degrading enzymes require zinc (Zn2+) as a structural
component (Page-McCaw et al., 2007). Indeed, Zn2+ acts as
an activator or coactivator of a variety of proteins by providing
a structural scaffold, for example in the form of zinc fingers
and zinc clusters (Prasad, 1995). Zn2+ is also found in the cyto-
plasm and intracellular compartments in a labile form, and
changes in these Zn2+ levels affect various cellular functions. In
fact, an imbalance in Zn2+ homeostasis is linked to abnormal
embryonic development, immune dysfunction, neurological
problems, and increased mortality and disease (Fukada et al.,
2011). Zn2+ may also be overtly toxic when accumulated in
excess in cells. Therefore, normal cell functioning requires tight
regulation of Zn2+ homeostasis. Zn2+ homeostasis is primarily
regulated by membrane Zn2+ transporters of the Slc30a family
(ZNT) of exporters and Slc39a family (ZIP) of importers (Cousins
et al., 2006). The ZNT family, consisting of ten members in mam-
mals (ZNT1–ZNT10), mediates Zn2+ efflux from cells or influx into
intracellular vesicles from the cytosol. There are 14 members of
the ZIP family of Zn2+ importers in mammals (ZIP1–ZIP14) that
promote Zn2+ influx from the extracellular fluid or intracellular
vesicles into the cytoplasm. Zn2+ transporters exhibit tissue-
specific functions (Liuzzi et al., 2005; Kitamura et al., 2006),
and abnormalities in the function of certain Zn2+ transporters
are associated with human diseases, such as acrodermatitis
enteropathica (Ku¨ry et al., 2002). Zn2+ influxmodulates a number
of transcription factors in various cell types. Among them, metal-
regulatory transcription factor-1 (MTF1) regulates expression
of a variety of target genes and thereby regulates cellular
adaptation to various stress conditions, primarily exposure to
heavy metals, but also hypoxia and oxidative stress (Laity and
Andrews, 2007; Gu¨nther et al., 2012). Zn2+ homeostasis is addi-
tionally regulated by metal-dependent transcriptional control of
storage proteins. For instance, metallothioneins (MTs), whose
genes are well-known targets of MTF1, act as Zn2+-storage pro-
teins and thereby regulate cellular Zn2+ homeostasis. MTs also
act as antioxidants and protect cells from oxidative stress (Laity
and Andrews, 2007; Colvin et al., 2010; Gu¨nther et al., 2012).
There has been a growing interest in the potential role of Zn2+
in the pathogenesis of OA. Clinical studies indicate highly
elevated serum Zn2+ levels in OA patients (Ovesen et al., 2009)
and specific accumulation of Zn2+ in the tidemark region of artic-
ular cartilage in aged populations (Roschger et al., 2013). The as-
sociation of Zn2+ with OA pathogenesis is broadly appreciated in
the context of its role as a structural component of matrix-de-
grading enzymes required for the maturation and activation of
these enzymes. However, how Zn2+ homeostasis is regulated
during the onset and progression of OA and how it contributes
to the pathological transition of articular chondrocytes remain
unknown. Here, we investigated the roles of Zn2+ homeostasis,
homeostasis-regulating Zn2+ transporters, and downstream
transcription factors and their target genes in OA pathogenesis.
We report here that the zinc-ZIP8-MTF1 axis regulates OA
pathogenesis.
RESULTS
The Zn2+ Influx Mediator ZIP8 Is Upregulated in
Chondrocytes under Pathological Conditions and in OA
Cartilage
To elucidate the role of Zn2+ homeostasis and associated regu-
latory genes in OA pathogenesis, we initially examined expres-
sion levels of metal ion transporters—the Slc30a family (ZNT)
of exporters and Slc39a family (ZIP) of importers—in primary cul-
tures of mouse articular chondrocytes. Among the examined
transporters, ZNT9 and ZIP7 mRNAs were expressed at rela-
tively high levels in chondrocytes, whereas many of the remain-
ing transporters were barely detectable (Figure 1A). However,
following treatment with interleukin (IL)1b, a proinflammatory
cytokine that promotes catabolism in arthritic cartilage (Kapoor
et al., 2011), ZIP8 expression levels were markedly increased,
making it the most dominantly expressed transporter among
the ZNT and ZIP familymembers (Figure 1A). This led us to inves-
tigate the role of ZIP8 in OA pathogenesis. ZIP8 is known to
transport Zn2+, nontransferrin-bound Fe2+, Mn2+, and Cd2+
(Dalton et al., 2005; Wang et al., 2012). We therefore examined
whether ZIP8 transports these metal ions in mouse articular
chondrocytes. Overexpression of ZIP8 in chondrocytes caused
significant Zn2+ influx (Figures 1B and 1C), whereas cellular
levels of Fe2+, Mn2+, and Cd2+ were not affected by ZIP8 overex-
pression alone (Figure 1B). However, in a certain range of each
metal ion supplementation, ZIP8 effectively drove influx of these
metal ions (Figure 1B), suggesting that the transport efficiency of
each metal ion by ZIP8 is determined by the cellular microenvi-
ronmental context, with Zn2+ evidently being the most efficiently
transported by ZIP8 under our experiment conditions. Thus, we
further characterized the regulation of Zn2+ influx by ZIP8. TheZIP8-mediated increase in Zn2+ influx was abolished by the
cell-impermeable metal ion chelator, calcium-saturated EDTA
(CaEDTA), or the cell-permeable chelator, N,N,N’,N’-tetrakis
(2-pyridylmethyl) ethylenediamine (TPEN) (Figure 1C). IL1b,
which increased both transcript and protein levels of ZIP8 (Fig-
ure 1A, inset), caused an influx of Zn2+ in chondrocytes that
was blocked by downregulating Zip8 with small interfering
RNA (siRNA) or the metal ion chelators CaEDTA or TPEN
(Figure 1C).
The upregulation of ZIP8 and Zn2+ influx in chondrocytes un-
der pathological conditions (i.e., exposure to IL1b) suggests
the possible association of ZIP8-mediated Zn2+ influx with OA
pathogenesis. This was evaluated by examining expression of
ZIP8 and Zn2+ levels in OA cartilage of human and mouse
models. Damage of OA-affected human cartilage was estab-
lished based on Alcian blue staining (Figure 1D). Zn2+ and ZIP8
protein andmRNA levels were markedly elevated in OA-affected
human cartilage but were barely detectable in undamaged re-
gions of arthritic cartilage (Figure 1D). We also used destabiliza-
tion of the medial meniscus (DMM) surgery as a mouse model of
OA and compared it with normal cartilage in a sham-operated
joint (Glasson et al., 2007). Similar to human OA cartilage, mouse
OA cartilage showed amarked increase in Zn2+ and ZIP8 protein
and mRNA levels (Figure 1E).
ZIP8-Mediated Zn2+ Influx Induces Upregulation of
Matrix-Degrading Enzymes in Chondrocytes
The increased expression of ZIP8 and elevated Zn2+ levels in OA
cartilage suggests their possible involvement in OA pathogen-
esis. A hallmark of OA chondrocytes is their increased produc-
tion of Zn2+-bound matrix-degrading enzymes such as MMPs
and ADAMTSs. We therefore asked whether cellular Zn2+ influx
driven by ZIP8 is sufficient to cause expression of matrix-
degrading enzymes. Among the examined enzymes, MMP3,
MMP9,MMP12,MMP13, and ADAMTS5were significantly upre-
gulated by infection of chondrocytes with an adenoviral Zip8
expression construct (Ad-Zip8); this effect was blocked by metal
ion chelation with CaEDTA or TPEN (Figure 2A). Consistent with
this, treatment of chondrocytes with ZnCl2 upregulated MMP3,
MMP9, MMP12, and MMP13, whereas treatment with CdCl2 or
MnCl2 did not cause a marked expression of matrix-degrading
enzymes (Figure 2B). FeCl2 treatment caused moderate expres-
sion of matrix-degrading enzymes. However, chelation of ferric
or ferrous with Zn/DFO or 2,2-bipyridyl, respectively, did not
affect Ad-Zip8-induced expression of matrix-degrading en-
zymes (Figure 2C), consistent with the fact that ZIP8 did not
cause Fe2+ influx without exogenous FeCl2 supplementation.
Furthermore, preincubation of TPEN with ZnCl2 effectively abol-
ished the inhibitory effects of TPEN on the ZIP8-mediated
expression of matrix-degrading enzymes, whereas FeCl2,
CdCl2, and MnCl2 showed no significant effects on TPEN inhibi-
tion of the ZIP8-mediated upregulation of matrix-degrading en-
zymes (Figure 2D). These results collectively suggest that Zn2+,
among the metal ions transported by ZIP8, plays a major role
in ZIP8 regulation of the expression of matrix-degrading en-
zymes. Among the ZIP8-regulated matrix-degrading enzymes,
MMP3, MMP13, and ADAMTS5 are crucial effectors of OA carti-
lage destruction (Blom et al., 2007; Glasson et al., 2005; LittleCell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc. 731
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et al., 2009). Indeed, upregulation of these enzymes by IL1b was
abolished by knockdown of Zip8with specific siRNA or by metal
ion chelation with CaEDTA or TPEN (Figures 2E and 2F). Collec-
tively, these results suggest ZIP8-mediated Zn2+ influx exerts a
catabolic function in chondrocytes by virtue of its role in upregu-
lating matrix-degrading enzymes.
ZIP8 Overexpression in Cartilage Tissue Causes OA
Pathogenesis in Mice
The role of ZIP8-mediated Zn2+ influx in OA pathogenesis was
directly examined by intra-articular (IA) injection of Ad-Zip8
into mouse knee joints. We have previously shown that the
adenoviral system effectively delivers genes into mouse joint tis-
sues (Yang et al., 2010; Ryu et al., 2011, 2012; Oh et al., 2012)
and further confirmed gene delivery via this system by injecting
Ad-eGFP (Figure S1B available online). Ad-Zip8 injection
caused ZIP8 overexpression in cartilage, meniscus, ligament,
and synovium (Figures 3A and S1A). Three weeks after
Ad-Zip8 injection, chondrocytes of cartilage tissue exhibited
markedly increased levels of Zn2+, MMP3, and MMP13 (Fig-
ure 3A) with concomitant cartilage destruction (Figures 3B and
3C). IA injection of Ad-Zip8 also caused synovitis (Figure S1C).
Consistent with this, overexpression of ZIP8 in primary cultured
mouse fibroblast-like synoviocytes caused upregulation of
various catabolic factors, including matrix-degrading enzymes,
cytokines, and chemokines (Figure S1D). Additionally, Ad-Zip8-
induced MMP expression, cartilage destruction, and synovitis
were significantly blocked by coinjection of TPEN (Figures 3A,
3B, and S1C). Other OA manifestations, such as osteophyte
development and subchondral bone sclerosis, were not
observed at 3 weeks after Ad-Zip8 injection. However, 8 weeks
after IA injection, joint tissues exhibited osteophyte develop-
ment and subchondral bone sclerosis with more severe
cartilage destruction (Figure S1E). Collectively, these results
demonstrate that ZIP8-mediated Zn2+ influx acts as a catabolic
regulator of OA pathogenesis.
The in vivo role of ZIP8-mediated Zn2+ influx in OA pathogen-
esis was further validated using chondrocyte-specific Zip8-over-
expressing transgenic (TG) mice (Col2a1-Zip8), in which Zip8
expression is driven by the promoter and enhancer region of
mouse Col2a1 (Yang et al., 2010; Oh et al., 2012). Col2a1-Zip8
TG mice expressed markedly enhanced levels of ZIP8 in carti-
lage and meniscus, but not in the synovium or ligaments, of joint
tissues (Figures 3D and S2A). Zip8 TG mice also showed
increased levels of Zn2+, MMP3, and MMP13 in cartilage tissue
(Figure 3D). Consistent with this, aged (12-month-old) Zip8 TG
mice exhibited spontaneous cartilage destruction (Figure 3E),
with Osteoarthritis Research Society International (OARSI)Figure 1. The Zn2+ Influx Mediator ZIP8 Is Upregulated in Chondrocyte
(A) mRNA levels of metal ion transporters determined by qRT-PCR in articular
chondrocytes treated with IL1b.
(B) Cellular levels of Zn2+, Fe2+/Fe3+, Mn2+, and Cd2+ were measured in chondr
centrations of ZnCl2, FeCl2, MnCl2, or CdCl2.
(C) Cellular Zn2+ levels were imaged and quantified in chondrocytes treated wit
infected with Ad-Zip8, with or without the metal chelator, CaEDTA or TPEN (n =
(D and E) Staining of cartilage with Alcian blue or safranin-O, imaging and quantific
quantification of ZIP8 mRNA levels by qRT-PCR in human OA cartilage (D) or mo
Scale bar, 50 mm. Values are presented as means ± SEM (*p < 0.05, **p < 0.01,grades ranging from 1 to 6 (Figure S2D) and subchondral bone
sclerosis (Figure 3F) compared with age-matched wild-type
(WT) mice; synovitis was not observed in Zip8 TG mice (Fig-
ure 3G). Additionally, DMM surgery in young (10–12 weeks old)
Zip8 TG mice showed significantly enhanced OA cartilage
destruction (Figure 3H) and subchondral bone sclerosis,
whereas synovitis and osteophyte development were not
affected (Figures S2E and S2F). These features of Zip8 TG
mice clearly support the notion that ZIP overexpression in carti-
lage tissue is sufficient to cause OA pathogenesis.
Zip8 Knockout in Mice Inhibits Experimental OA
Pathogenesis
We next confirmed the catabolic role of ZIP8 in OA pathogenesis
using Zip8-knockout (KO) mice. Because homozygous deletion
of Zip8 in mice (Zip8/) is embryonic lethal (Ga´lvez-Peralta
et al., 2012), we evaluated the effect of Zip8 knockout on
OA pathogenesis using chondrocyte-specific conditional KO
(CKO) mice (Zip8fl/fl;Col2a1-Cre). Zip8-CKO mice showed a sig-
nificant reduction in OA cartilage destruction following DMMsur-
gery (Figure 4A), with concomitant inhibition of ZIP8 expression,
Zn2+ influx, and expression of MMP3 and MMP13 in cartilage
tissue (Figure 4B). Consistent with this, IL1b-induced Zn2+ influx
and expression of MMP3, MMP13, and ADAMTS5were reduced
in primary cultured chondrocytes isolated from Zip8-CKO mice
(Figures 4C and 4D). In addition to cartilage destruction, DMM-
operated Zip8-CKO mice exhibited significant inhibition of
subchondral bone sclerosis, whereas synovitis and osteophyte
formation were not affected (Figures 4E and 4F). The results
collectively suggest that genetic deletion of Zip8 inhibits experi-
mental OA pathogenesis in mice. Similar to Zip8 CKO mice,
Zip8+/ mice also exhibited reduced OA cartilage destruction
and subchondral bone sclerosis following DMM surgery (data
not shown).
ZIP8-Mediated Zn2+ Influx Upregulates Matrix-
Degrading Enzymes by EnhancingMTF1 Transcriptional
Activity
Next, we elucidated the regulatory mechanisms by which ZIP8-
mediated Zn2+ influx mediates catabolic factor expression and
OA pathogenesis. To do this, we first identified transcription fac-
tors activated by ZIP8-mediated Zn2+ influx in chondrocytes us-
ing a transcription factor array kit. Among the 37 transcription
factors examined, MTF1, NRF1 and NRF2, NF-kB, SP1, p53,
C/EBP, and AP1 showed more than a 3-fold increase in tran-
scriptional activity following Ad-Zip8 infection (Figure S3A).
Pharmacological inhibition of p53, AP1, or NF-kB or siRNA-
mediated knockdown of Nrf or Cebpb had no significant effects under Pathological Conditions and in OA Cartilage
chondrocytes treated with IL1b (n = 10). Inset is western blotting of ZIP8 in
ocytes infected with Ad-C or Ad-Zip8 following treatment with indicated con-
h ZnCl2 or IL1b, with or without control (C) or Zip8 siRNA, or in chondrocytes
5–12).
ation of Zn2+ levels with fluorophore, detection of ZIP8 by immunostaining, and
use OA cartilage induced by DMM surgery (E) (nR 8).
***p < 0.001). NS, not significant. See also Table S1.
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Figure 2. ZIP8-Mediated Zn2+ Influx Induces Upregulation of Matrix-Degrading Enzymes in Chondrocytes
(A and B) mRNA levels were quantified by qRT-PCR in chondrocytes infected with Ad-C or Ad-Zip8 with or without CaEDTA or TPEN (nR 6) (A) or treated with
100 mM of ZnCl2, FeCl2, or MnCl2 and 1 mM of CdCl2 (n = 6) (B).
(C) The indicated mRNAs were detected in chondrocytes infected with Ad-C or Ad-Zip8 in the absence or presence of the indicated concentrations of iron
chelators, Zn/DFO, 2,2-bipyridyl, or Mn2+ chelator para-aminosalicylic acid (PAS) (n = 4).
(D) mRNA levels of matrix-degrading enzymes in chondrocytes infected with Ad-C or Ad-Zip8with or without TPEN (1 mM) or TPEN preincubated with 1 mMof the
indicated metal ion (n = 5).
(E) qRT-PCR analysis (nR 6) of mRNA levels of ZIP8 and matrix-degrading enzymes in chondrocytes treated with IL1b, with or without control or Zip8 siRNA,
TPEN, or CaEDTA.
(F) Expression of matrix-degrading enzymes, determined by western blotting.
Values are presented as means ± SEM (*p < 0.05, **p < 0.01, ***p < 0.001). See also Table S1.
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Figure 3. ZIP8 Overexpression in Cartilage Tissue Causes OA Pathogenesis in Mice
(A–C) Mice were IA injected with Ad-C or Ad-Zip8 with or without TPEN. ZIP8, MMP3, and MMP13 in cartilage were detected by immunostaining, and Zn2+ was
imaged using a fluorophore (A). Cartilage destruction was detected by safranin-O staining (B) and quantified by OARSI grade (nR 13) (C).
(D) Cartilage sections from 12-week-old WT and Zip8 TG mice were immunostained for ZIP8, MMP3, and MMP13. Zn2+ was imaged using a fluorophore.
(E) Spontaneous cartilage destruction in aged (12-month-old) WT and Zip8 TG mice (n = 16).
(F and G) Subchondral bone sclerosis (F) and synovitis (G) in 12-month-old WT and Zip8 TG mice (n = 16).
(H) Cartilage destruction in 18- to 20-week-old DMM-operated WT and Zip8 TG mice (n = 12).
Scale bar, 50 mm. Values are presented as means ± SEM (*p < 0.001). See also Figures S1 and S2.on Ad-Zip8-induced upregulation of matrix-degrading enzymes
(Figures S3C and S3D). However, knockdown ofMtf1with siRNA
or inhibition of SP1 with mithramycin-A significantly attenuated
ZIP8-induced upregulation of matrix-degrading enzymes (Fig-
ures S3E and S3G). Based on these observations and the fact
that MTF1 is a master transcriptional regulator of cellular adap-
tation under conditions of exposure to heavy metals (Laity andAndrews, 2007; Gu¨nther et al., 2012), we selected MTF1 for
functional characterization in ZIP8-induced OA pathogenesis.
Ad-Zip8 infection promoted the nuclear localization of MTF1
(Figure 5A) and significantly increased its transcriptional activity
(Figure 5B) without modulating its expression (Figure S4A).
Notably, adenoviruses expressing mouse Mtf1 (Ad-Mtf1) infec-
tion significantly upregulated expression of matrix-degradingCell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc. 735
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Figure 4. Genetic Deletion of Zip8 in Mice Inhibits OA pathogenesis
(A) Cartilage sections from sham- and DMM-operated Zip8fl/fl and chondrocyte-specific CKO mice (B) were stained with safranin-O. Cartilage destruction was
quantified by OARSI grade (n = 10).
(B) CRE, ZIP8, MMP3, and MMP13 were detected by immunostaining, and Zn2+ was imaged in cartilage sections from Zip8fl/fl and Zip8-CKO mice after DMM
surgery or sham operation.
(C and D) Primary cultured chondrocytes isolated from Zip8fl/fl and Zip8-CKO mice were treated with IL1b. Zn2+ was imaged and quantified using a fluorophore.
mRNA levels of ZIP8 (C) and matrix-degrading enzymes (D) were determined by qRT-PCR (nR 4).
(E and F) Synovitis (E) and subchondral bone sclerosis/osteophyte formation (F) in sham- and DMM-operated Zip8fl/fl and Zip8-CKO mice (n = 10).
Scale bar, 50 mm. Values are presented as means ± SEM (*p < 0.01, **p < 0.005, ***p < 0.001). See also Table S1.enzymes (MMP3, MMP9, MMP12, MMP13, and ADAMTS5), an
effect that was abolished by CaEDTA or TPEN (Figures 5C and
5D). Additionally, ZIP8 or Zn2+-induced upregulation of matrix-
degrading enzymes was significantly reduced by siRNA-medi-
ated knockdown of Mtf1 (Figures S3E and S3F). Among the
ZIP8-regulated metal ions, Zn2+ was the most effective in regu-736 Cell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc.lating nuclear localization and transcriptional activation of
MTF1 and Fe2+ andMn2+ had no effect onMTF1 activity (Figures
S4B and S4C). Although Cd2+ caused a moderate activation of
MTF1 (Figure S4C), it had no significant effect on the expression
of matrix-degrading enzymes, except for a modest induction of
MMP12 expression (Figure 2B). This suggests that, unlike the
A B
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Figure 5. ZIP8-Mediated Zn2+ Influx Upregulates Matrix-Degrading Enzymes through Activation of MTF1
(A) Immunostaining for MTF1 and quantification of cells with nuclear-localized MTF1.
(B) MTF1 transcriptional activity quantified by reporter gene assay in chondrocytes treated with ZnCl2 or infected with Ad-C, Ad-Zip8, or Ad-Mtf1with or without
TPEN (n = 9).
(C) mRNA levels in chondrocytes infected with Ad-C or Ad-Mtf1 (nR 5) in the absence or presence of CaEDTA or TPEN.
(D) Protein levels of MTF1 and matrix-degrading enzymes.
Values are presented as means ± SEM (*p < 0.01, **p < 0.001). See also Figures S3 and S4 and Table S1.effects of Zn2+-dependent activation of MTF1, Cd2+-induced
MTF1 activation does not cause expression of matrix-degrading
enzymes. This discrepancy may reflect the fact that MTF1
regulates target-gene expression in a metal-specific manner
(Gu¨nther et al., 2012). Additionally, preincubation of TPEN with
ZnCl2, but not FeCl2, CdCl2, or MnCl2, abolished the inhibitory
effects of TPEN on MTF1 transcriptional activity (Figure S4D).
These results collectively suggest that ZIP8-mediated Zn2+
influx promotes MTF1 transcriptional activity, which in turn
upregulates expression of matrix-degrading enzymes in
chondrocytes.
MTF1 Mediates ZIP8-Induced OA Pathogenesis in Mice
We next examined the in vivo role of MTF1 in OA pathogenesis.
In human cartilage tissues, both MTF1 mRNA and protein were
detected at high levels in OA-affected cartilage tissue compared
with undamaged regions of arthritic cartilage (Figure 6A). The
in vivo function of MTF1 was evaluated by IA injection of Ad-Mtf1in mice, which caused MTF1 overexpression in the joint tissues
(Figures 6B and S5A). Expression levels of MTF1, MMP3, and
MMP13 in the chondrocytes of cartilage tissue were markedly
enhanced at 3 weeks after Ad-Mtf1 injection (Figure 6B) with
concomitant cartilage destruction (Figure 6C). IA injection of
Ad-Mtf1 also caused synovial inflammation (Figure S5B), and
overexpression of MTF1 in fibroblast-like synoviocytes caused
upregulation of various catabolic factors, including matrix-de-
grading enzymes, cytokines, and chemokines (Figure S5C).
Similar to the effects of Ad-Zip8 injection, Ad-Mtf1 injection in
mice caused osteophyte formation and subchondral bone scle-
rosis at 8 weeks after IA injection, with more severe cartilage
destruction (Figure S5D).
We also confirmed MTF1 function in OA pathogenesis
using Mtf1-KO mice. Chondrocyte-specific CKO mice (Mtf1fl/fl;
Col2a1-Cre) exhibited significantly reduced OA cartilage
destruction followingDMMsurgery (Figure 6D), with concomitant
reduction of the expression MTF1, MMP3, and MMP13Cell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc. 737
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Figure 6. MTF1 Is a Catabolic Regulator of OA Pathogenesis in Mice
(A) MTF1 protein and transcript levels in human OA cartilage determined by immunostaining and qRT-PCR, respectively (n = 10).
(B and C) Mice were IA injected with Ad-C or Ad-Mtf1. MTF1, MMP3, and MMP13 immunostaining in cartilage sections (B). Safranin-O staining and scoring of
cartilage destruction (nR 14) (C).
(D and E) Cartilage sections from sham- and DMM-operated Mtf1fl/fl and Mtf1-CKO mice were stained with safranin-O, and cartilage destruction was scored
(n = 10) (D) and immunostained for CRE, MTF1, MMP3, and MMP13 (E).
(F) Subchondral bone sclerosis/osteophyte formation and synovitis in sham- and DMM-operated Mtf1fl/fl and Mtf1-CKO (n = 10).
Scale bar, 50 mm. Values are presented as means ± SEM (*p < 0.001). See also Figures S5, S6, and S7 and Table S1.(Figure 6E). DMM-operatedMtf1-CKOmice also exhibited inhibi-
tion of subchondral bone sclerosis without significant effects on
synovitis or osteophyte formation (Figure 6F). Additionally,
DMM-operated Mtf1+/ mice (homozygous deletion of Mtf1 is
embryonic lethal; Wang et al., 2004) also exhibited reduced
cartilage destruction, subchondral bone sclerosis, and expres-
sion of MMP3 andMMP13 (data not shown). To further elucidate
MTF1 as themediator of ZIP8 functions, we IA coinjectedMtf1fl/fl738 Cell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc.mice with Ad-Zip8 and Ad-Cre to locally delete Mtf1 in joint tis-
sues. This local deletion of Mtf1 significantly inhibited Ad-Zip8-
induced cartilage destruction and synovitis (Figure S6A). In
contrast, local deletion of Zip8 by Ad-Cre injection in Zip8fl/fl
mice did not affect Ad-Mtf1-induced cartilage destruction or
synovitis (Figure S6B). This clearly supports the notion that
MTF1 is a downstream mediator of ZIP8 in OA pathogenesis
and ZIP8-activated MTF1 acts as a catabolic regulator of OA
cartilage destruction by upregulating matrix-degrading enzymes
in chondrocytes.
Finally, we explored the effects of dietary Zn2+ supplementa-
tion on surgically induced OA. Low-Zn2+ diet did not affect
DMM-induced OA cartilage destruction, presumably due to
trace amount of Zn2+ (<0.5 mg zinc/kg). However, mice fed
a high-Zn2+ diet exhibited enhanced cartilage destruction
following DMM surgery (Figure S7A). Consistent with this, intra-
peritoneal administration of ZnCl2 augmented DMM-induced
cartilage destruction (Figure S7B). Taken together, these obser-
vations indicate that Zn2+ levels are positively correlated with OA
pathogenesis, consistent with our findings that ZIP8-mediated
Zn2+ influx and MTF1 activation favor OA development.
Knockout of MT Genes Enhances OA Cartilage
Destruction in Mice
MTs, which are well-known targets of MTF1, regulate Zn2+ ho-
meostasis by virtue of their function as Zn2+-storage proteins,
and they protect cells from oxidative stress by acting as antiox-
idants (Laity and Andrews, 2007; Colvin et al., 2010; Fukada
et al., 2011). We therefore elucidated possible functions of
MTs in OA pathogenesis. Expression of Mt1 and Mt2, which
encode the closely related MT1 and MT2 proteins, was signifi-
cantly increased in primary cultured chondrocytes infected
with Ad-Zip8 or Ad-Mtf1 or treated with ZnCl2 (Figures 7A
and 7B). The in vivo significance of MT1/MT2 in OA patho-
genesis was evaluated using Mt1/;Mt2/ double-KO mice.
Compared with WT mice, DMM-operated Mt1/;Mt2/ dou-
ble-KO mice exhibited significantly enhanced OA cartilage
destruction (Figure 7C) and subchondral bone sclerosis without
significant effects on synovitis and osteophyte formation (Fig-
ures 7D and 7E). These results collectively suggest that MTF1
activation caused by ZIP8-mediated Zn2+ influx activates a cata-
bolic cascade by upregulating matrix-degrading enzymes,
whereas upregulation of MT1 and MT2 proteins by MTF1 forms
a negative feedback loop that alleviates zinc-cascade-induced
OA pathogenesis.
DISCUSSION
The hallmark of OA is the accelerated catabolism elicited by the
increased expression ofMMPs and ADAMTSs. Thesematrix-de-
grading enzymes require Zn2+ for their maturation and catalytic
activity, suggesting an association of intracellular Zn2+ homeo-
stasis with OA pathogenesis. However, no evidence available
to date clearly indicates the involvement of Zn2+ homeostasis
and the genes that regulate it in OA pathogenesis. We demon-
strated here that the zinc-ZIP8-MTF1 axis, comprising the Zn2+
importer ZIP8, Zn2+ influx, and the Zn2+-dependent transcription
factor MTF1, is an essential catabolic regulator of experimental
OA pathogenesis in mice. We additionally demonstrated that
MT1 and MT2 proteins, which are targets of MTF1, form a nega-
tive feedback loop that inhibits zinc-cascade-induced OA
pathogenesis.
Zn2+ acts as an activator or coactivator of proteins by
providing a structural scaffold, such as zinc fingers and zinc
clusters (Prasad, 1995). Indeed, there are more than 100
Zn2+-dependent enzymes and more than 2,000 Zn2+-dependenttranscription factors in mammals (Andreini et al., 2006). The
matrix-degrading enzymes involved in OA cartilage destruction
also require Zn2+ as a structural component (Page-McCaw
et al., 2007). In this study, we revealed that Zn2+ influx is involved
in the transcriptional upregulation of MMP3, MMP9, MMP12,
MMP13, and ADAMTS5 in articular chondrocytes. Among these,
MMP3, MMP13, and ADAMTS5 are crucial effectors of OA carti-
lage destruction (Blom et al., 2007; Glasson et al., 2005; Little
et al., 2009). These results clearly support the notion that in-
creases in cellular Zn2+ play a catabolic role in OA pathogenesis
by upregulating matrix-degrading enzymes in articular chondro-
cytes. Zn2+ homeostasis is regulated by the complex interplay
of uptake and efflux transporter proteins coupled with metal-
dependent transcriptional control of transporters and storage
proteins (Cousins et al., 2006; Laity and Andrews, 2007; Gu¨nther
et al., 2012). Membrane Zn2+ transporters are primarily respon-
sible for the regulation of Zn2+ homeostasis. We found that
ZIP8, among 24 examined importers and exporters, is specif-
ically upregulated in chondrocytes under pathological condition
and is responsible for Zn2+ influx. We additionally demonstrated
that, among the ZIP8-transported metal ions (Zn2+, Fe2+, Mn2+,
and Cd2+), Zn2+ influx is the essential event that initiates the
activation of catabolic cascades in OA chondrocytes. Consis-
tent with this, blocking ZIP8-mediated Zn2+ influx effectively
suppressed catabolic factor expression and experimental OA
pathogenesis.
Zn2+ influx causes activation of Zn2+-sensing, metal-depen-
dent transcription factors (Laity and Andrews, 2007; Gu¨nther
et al., 2012). In articular chondrocytes, ZIP8-mediated Zn2+ influx
activated numerous transcription factors, including MTF1,
NRF1/NRF2, NF-kB, SP1, p53, C/EBP, and AP1. Among these
activated transcription factors, MTF1 and SP1 were associated
with the ZIP8-mediated expression of matrix-degrading en-
zymes. MTF1 is involved in cellular adaptation to various stress
conditions, primarily exposure to heavy metals such as Zn2+
but also hypoxia and oxidative stress. This function of MTF1 is
associated with its ability to regulate expression of a variety of
target genes (Laity and Andrews, 2007; Gu¨nther et al., 2012).
We found that MTF1 activation in chondrocytes is sufficient to
induce expression of the matrix-degrading enzymes, MMP3,
MMP9, MMP12, MMP13, and ADAMTS5. These enzymes were
also upregulated by ZIP8-mediated Zn2+ influx, suggesting that
ZIP8 acts through MTF1 to induce expression of matrix-degrad-
ing enzymes. Indeed, the OA pathogenesis caused by Ad-Zip8
injection was significantly inhibited in Mtf1-deficient mice,
whereas Ad-Mtf1-caused OA pathogenesis was not affected in
Zip8-deficient mice. This clearly suggests that MTF1 is a down-
stream mediator of ZIP8 in OA pathogenesis. However, siRNA-
mediated knockdown of Mtf1 or genetic deletion of Mtf1 in
mice did not completely block ZIP8-mediated catabolic factor
expression and OA pathogenesis, respectively. This suggests
that other factors in addition to MTF1 are likely involved in
ZIP8-mediated expression of matrix-degrading enzymes and,
hence, OA pathogenesis. It is well appreciated that regulatory
pathways of gene expression are very complex, with multiple
factors in each regulatory step. Indeed, our current results
revealed that inhibition of SP1, which is activated by ZIP8-medi-
ated Zn2+ influx, blocked the upregulation of matrix-degradingCell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc. 739
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Figure 7. Double Knockout of Mt1 and Mt2 Enhances OA Pathogenesis in Mice
(A) mRNA levels of MT1 and MT2 in chondrocytes infected with Ad-Zip8 or Ad-Mtf1 or treated with ZnCl2 (nR 6).
(B) Detection of MT1/MT2 proteins in chondrocytes treated with ZnCl2 or infected with Ad-Zip8, Ad-Mtf1.
(C–E) Cartilage destruction (C), synovitis (D), osteophyte formation, and subchondral bone sclerosis (E) in sham- and DMM-operated WT and Mt1/;Mt2/
double-KO mice (n = 13).
Scale bar, 50 mm. Values are presented as means ± SEM (*p < 0.005, **p < 0.001). See also Table S1.enzymes induced by Ad-Zip8 infection, suggesting that SP1 is
also associated with ZIP8-induced OA pathogenesis. Neverthe-
less, IA injection of Ad-Mtf1 caused OA pathogenesis, whereas
Mtf1-KO mice exhibited suppressed DMM-induced OA patho-
genesis. This clearly supports the notion that MTF1 functions
as an essential downstream mediator of ZIP8-induced OA path-740 Cell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc.ogenesis by virtue of its role in upregulating matrix-degrading
enzymes.
OA is primarily characterized by cartilage destruction. How-
ever, OA is considered to be a whole-joint disease, with
pathological changes, including cartilage destruction, synovial
inflammation, osteophyte development, and subchondral bone
sclerosis occurring in all tissues of the joint (Bian et al., 2012;
Loeser et al., 2012; Little and Hunter, 2013). Therefore, biochem-
ical and biomechanical crosstalk among different joint tissue
compartments likely plays an important role in the onset and pro-
gression of OA. In this context, synovial inflammation in the joint
tissue might contribute to OA pathogenesis by promoting the
production of various OA-regulating factors (i.e., cytokines and
chemokines) by synovial cells (Scanzello and Goldring, 2012).
Indeed, we found that IA injection of Ad-Zip8 or Ad-Mtf1 pro-
moted the expression of various matrix-degrading enzymes,
cytokines, and chemokines in fibroblast-like synoviocytes and
caused synovial inflammation, effects that were blocked by
coinjection of the metal chelator TPEN. Although a contribution
of this synovitis to cartilage destruction cannot be ruled out,
the spontaneous cartilage destruction observed upon aging
and the enhanced cartilage destruction induced by DMM sur-
gery in Col2a1-Zip8 TG mice, without apparent synovial inflam-
mation, suggests that activation of the zinc cascade in chondro-
cytes is sufficient to cause OA pathogenesis. In addition to
cartilage destruction and synovitis, IA injection of Ad-Zip8 or
Ad-Mtf1 caused subchondral bone sclerosis and osteophyte for-
mation. Consistent with this, genetic deletion of Zip8 or Mtf1 in
mice effectively inhibited cartilage destruction and subchondral
bone sclerosis, whereas overexpression of Zip8 in Col2a1-Zip8
TG mice enhanced these manifestations. Therefore, changes
in cartilage destruction and subchondral bone sclerosis caused
by genetic modulation of Zip8 and Mtf1 are highly correlated.
However, whereas these correlations have been noted in various
OA models, it is still unclear how these two compartments
interact each other and which of these two events is more criti-
cally associated with the initiation of OA. Given the nature of
Col2a1 promoter-driven expression in the TG and CKO mice
used in this study, it is likely that subchondral bone sclerosis is
a consequence of the altered functions of chondrocytes in artic-
ular cartilage. For example, accelerated cartilage damage in
Zip8 TG mice would augment the mechanical stress imposed
on the underlying bone, whereas reduced cartilage degeneration
in Zip8- orMtf1-CKOmice would alleviate the loading caused by
joint instability in the subchondral bone, thereby ameliorating
subchondral bone sclerosis. In contrast, genetic modulation of
Zip8 and Mtf1 in mice did not affect osteophyte formation, indi-
cating that catabolic pathways regulated by ZIP8 and MTF1 are
not associated with this process. This notion is further supported
by reports that deletion of either Mmp13 or Adamts5, which are
the key effectors of OA catabolism, does not prevent osteophyte
development in a surgically induced OA model (Botter et al.,
2009; Little et al., 2009).
Metal-sensing MTF1 also regulates Zn2+ homeostasis by
modulating selective Zn2+ transporters and MTs (Laity and
Andrews, 2007; Gu¨nther et al., 2012). MTs, which are small
cysteine-rich proteins, bind to Zn2+ and thereby regulate cellular
Zn2+ concentration and intracellular distribution (Blindauer and
Leszczyszyn, 2010). In addition to this Zn2+-storage function,
MTs also act as antioxidants. This antioxidant potential, as well
as the ability of MTs to suppress inflammatory cytokines,
including IL1b, protects against allergic inflammation (Penkowa
et al., 2001). Because MT1 and MT2 show high structural and
functional similarities, we used Mt1/;Mt2/ double-KO miceto elucidate MT functions in OA pathogenesis. Our finding that
Mt1/Mt2-deficient mice exhibited enhanced OA cartilage
destruction is consistent with the known functions of MTs as
Zn2+-storage and antioxidant proteins. Therefore, increased
cellular levels of MT1 and MT2 induced by ZIP8-mediated Zn2+
influx andMTF1 activation appear to function as a negative feed-
back loop to alleviate cartilage destruction.
Collectively, our results demonstrate that the zinc-ZIP8-MTF1
axis in chondrocytes forms a catabolic cascade that promotes
upregulation of the crucial effector matrix-degrading enzymes,
MMP3, MMP13, and ADAMTS5, thereby leading to OA cartilage
destruction. Our findings support the notion that local depletion
of Zn2+, inhibition of ZIP8 function and Zn2+ influx, and/or inhibi-
tion of MTF1 activity in cartilage tissue would be effective thera-
peutic approaches for the treatment of OA.
EXPERIMENTAL PROCEDURES
Human OA Cartilage Tissue
International Cartilage Repair Society grade 4 human OA cartilage was
sourced from individuals (age 51–72 years) undergoing arthroplasty. The Insti-
tutional Review Board of the Wonkwang University Hospital approved the use
of these materials, and all individuals provided full written informed consent
before the operative procedure.
Mice and Experimental OA
Male mice (C57BL/6, Col2a1-Zip8 TG, Zip8+/, Zip8fl/fl, Zip8fl/fl;Col2a1-Cre,
Mtf1+/, Mtf1fl/fl, Mtf1fl/fl;Col2a1-Cre, Mt1/;Mt2/) were used for experi-
mental OA studies. Chondrocyte-specific Zip8 TG (Col2a1-Zip8) mice were
generated using the Col2a1 promoter and enhancer. Zip8+/ mice were ob-
tained from The European Mouse Mutant Archive. The Mtf1 mouse strain
used for this research project was created from an embryonic stem cell clone
generated by the Wellcome Trust Sanger Institute and developed into mice by
the Knockout Mouse Project Repository and the Mouse Biology Program at
the University of California, Davis. Zip8+/ andMtf1+/mice were backcrossed
with Actb-Flp1 TG mice (The Jackson Laboratory) to generate Zip8fl/fl and
Mtf1fl/fl mice, respectively. These mice were then backcrossed with Col2a1-
Cre TG mice (The Jackson Laboratory) to generate chondrocyte-specific
CKO mice (Zip8fl/fl;Col2a1-Cre and Mtf1fl/fl;Col2a1-Cre). Mt1/;Mt2/ dou-
ble-KO mice were obtained from The Jackson Laboratory. The inbred strain
129S1/SvImJ was used as a control for Mt1/;Mt2/ double-KO mice. All
mice used in this study showed normal skeletal development (data not shown).
Animals were maintained under pathogen-free conditions. All experiments
were approved by the Gwangju Institute of Science and Technology Animal
Care and Use Committee. Experimental OA was induced by DMM surgery us-
ing 10- to 12-week-old male mice; sham-operated mice were used as controls
(Glasson et al., 2007). Knee joints were processed for histological analysis
8 weeks after surgery. However, in studies involving Col2a1-Zip8 TG mice
and Mt1/;Mt2/ double-KO mice, the duration after surgery was adjusted
to 6 weeks. Experimental OA was also induced by IA injection (once weekly
for 3 weeks) of Ad-Zip8 or Ad-Mtf1 (13 109 plaque-forming units in a total vol-
ume of 10 ml) into 10- to 12-week-old male mice; IA injection of empty adeno-
virus (Ad-C) was used as a control. Mice were sacrificed 3 or 8 weeks after the
first IA injection for histological and biochemical analyses. Where indicated,
the mice were coinjected (IA) with 0.1 mg/kg body weight of TPEN.
Histology and Immunohistochemistry
Human OA cartilage was frozen, sectioned at 10 mm thickness, and fixed in
paraformaldehyde. Sulfate proteoglycan was detected with Alcian blue stain-
ing. Human ZIP8 was detected by immunostaining. Cartilage destruction in
mice was examined using safranin-O staining. Briefly, knee joints were fixed
in 4% paraformaldehyde, decalcified in 0.5 M EDTA, and embedded in
paraffin. The paraffin blocks were sectioned at a thickness of 5 mm. Serial sec-
tions were obtained from the entire joint at 40 mm intervals. Sections wereCell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc. 741
deparaffinized in xylene, hydrated with graded ethanol, and stained with
safranin-O. Cartilage destruction was scored by two blinded observers using
the OARSI grading system (Glasson et al., 2010). Synovitis was determined by
safranin-O and hematoxylin staining, and synovial inflammation (grade 0–3)
was scored as described previously (Yang et al., 2010). Osteophyte develop-
ment was identified by safranin-O staining, and osteophytematurity was quan-
tified as described previously (Oh et al., 2012). Subchondral bone sclerosis
was determined by measuring the thickness of the subchondral bone plate
(Zhen et al., 2013). Antibodies used for immunostaining of cartilage sections
are described in detail in Extended Experimental Procedures.
Primary Culture of Articular Chondrocytes
Chondrocytes were isolated from femoral condyles and tibial plateaus of mice,
as described previously (Yang et al., 2010; Ryu et al., 2012; Oh et al., 2012).
Chondrocytes were maintained as a monolayer in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS)
and antibiotics, and cells at culture day 2 were treated as indicated in each
experiment.
Adenoviruses and Infection of Chondrocytes
Adenoviruses expressing mouse Zip8 (Ad-Zip8) and Ad-Mtf1 were purchased
from Vector Biolabs. Mouse articular chondrocytes were cultured for 2 days,
infected with Ad-C, Ad-Zip8, or Ad-Mtf1 for 2 hr at the indicated multiplicity
of infection (MOI), and cultured for 24 hr, followed by further analyses.
Transport of Metal Ions
Intracellular Zn2+, Fe2+/Fe3+, Mn2+, and Cd2+ were measured by using
FluoZin-3 AM, ferrozine assay, cellular Fura-2 manganese extraction assay,
and Leadmium Green AM, respectively. Detailed procedures are described
in Extended Experimental Procedures.
MTF1 Activity Reporter Gene Assay and Immunostaining
The MTF1 reporter gene assay kit was obtained from SABiosciences. Chon-
drocytes were transfected for 6 hr with a metal response element reporter
construct and a constitutive Renilla luciferase construct using Lipofectamine
2000 (Invitrogen). Transfected cells were infected with Ad-Mtf1 or Ad-Zip8
for 2 hr or treated with metal ions. Cells were harvested 24 hr after treatment,
and firefly luciferase and Renilla luciferase activities were measured using a
Dual Luciferase Assay System (Promega). For immunostaining, cells were
fixed in ice-cold 4% paraformaldehyde (pH 7.4), permeabilized with 0.2%
Triton X-100 in PBS, and serially blocked with Image-iT FX Signal Enhancer
(Invitrogen) and PBS containing 10% goat serum/0.1% bovine serum albumin.
MTF1 was detected by immunofluorescence microscopy. Images were ac-
quired using a fluorescence microscope, and at least 200 cells were examined
in multiple fields per condition to quantify the percentage of nuclear MTF1-
positive cells.
RT-PCR, qRT-PCR, and siRNA
Total RNAwas extracted from primary cultured chondrocytes using the TRI re-
agent (Molecular Research Center). For the isolation of RNA from knee joints,
cartilage tissues were scraped with a blade to remove cartilage and RNA was
isolated using the TRI reagent and Purelink RNA mini kit (Ambion). The RNA
was reverse transcribed, and the resulting cDNA was amplified by PCR.
PCR primers and experimental conditions are summarized in Table S1.
Transcript levels were quantified by quantitative RT-PCR (qRT-PCR). siRNAs
targeting Zip8 andMtf1were obtained from Dharmacon and transfected using
Lipofectamine 2000. Nontargeting (scrambled) siRNA was used as a negative
control. Chondrocytes were transfected by incubating for 6 hr with siRNA
and Lipofectamine 2000, as described by the manufacturer, and infected
with adenoviruses as described above.
Western Blotting
Total cell lysates were prepared in lysis buffer (150 mM NaCl, 1% NP-40,
50 mM Tris, 5 mM NaF) and used to detect cellular proteins (ZIP8, MTF1,
and ERK). Secreted proteins (MMP3, MMP13, and ADAMTS5) were detected
after trichloroacetic acid (TCA) precipitation from 900 ml of serum-free condi-
tioned medium. All lysis buffers contained a cocktail of protease inhibitors742 Cell 156, 730–743, February 13, 2014 ª2014 Elsevier Inc.and phosphatase inhibitors (Roche). Source of antibodies are described in
detail in Extended Experimental Procedures.
Statistical Analysis
Data quantified based on an ordinal grading system, such as OARSI grade,
were analyzed using nonparametric statistical methods. For qRT-PCR data
expressed as relative fold changes, Student’s t test and ANOVA with post
hoc tests were used for pairwise comparisons and multicomparisons, respec-
tively, after confirming a normal distribution using the Shapiro-Wilk test. Signif-
icance was accepted at the 0.05 level of probability (p < 0.05).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2014.01.007.
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